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Introduction
The myocardial perfusion imaging (MPI) using gated single 
photon emission computerized tomography (GSPECT) 
has been on the horizon of clinical cardiology of last four 
decades. The primary reasons for this popularity are its 
high diagnostic capability and ability to provide prognostic 
information useful in risk stratification and clinical decision 
making (1). There is a large body of data from various part 
of world indicating very high negative predictive value 
(NPV >99%) in patients with a normal SPECT MPI study 
(2,3). Gated MPI being a functional imaging modality is 
useful in ascertaining the hemodynamic significance of an 
anatomical lesion seen on coronary angiogram and allows 
risk stratification and guides about optimal management (4). 
Due to this very high NPV of a normal SPECT MPI, it has 
been considered as an efficient gatekeeper to catheterization 
laboratory (5). In recent years development in medical 
therapy and revascularization strategies have resultedin a 
growing number of patients with normal MPI who have 
a history of coronary artery diseases (CAD). Assessment 
of negative predictive of a normal MPI in this group of 
patients is important but currently data is limited with 
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varied outcomes, depending upon duration of follow-up in 
different studies (4,6,7). This certainly creates ambiguities 
in decision making in this clinical scenario. The aim of this 
study was to find out negative predictive value of normal 
GMPI in patients with history of CAD.
Methods
Study design and patients’ demographic
The was a prospective study conducted at Nuclear 
Cardiology Department of Karachi Institute of Heart 
Diseases (KIHD), Karachi, Pakistan. Consecutive patients 
were accrued from December 2008 till December 2011 
and followed till December 2013. The study was duly 
approved by the ethical committee of institute. We included 
428 consecutivepatients with a history of CAD, which 
was defined as a healed myocardial infarct (MI) and/or 
previous coronary revascularization, who had a normal 
stress Tc-99m-MIBI (99mTechnetium Methoxy IsoBytyl 
Isonitrile) GSPECT MPI. Dynamic exercise on treadmill 
was used (using Bruce or modified Bruce protocol) in 
255 (60%) patients while pharmacological stress using 
dipyridamole (0.142 mg/kg/min for 4 minutes) was adopted 
in 173 (40%). All patients were referred (272 inside and 
156 outside referrals) for assessment of ischemia (179 
patients asymptomatic; 249 patients with typical/atypical 
chest pain/dyspnea) Mean time interval between MPI and 
myocardial infarction (MI) was 3.2±4.6 years (118 patients) 
and revascularization was 1.9±3.2 years (310 patients). 
Patients with abnormal MPIs or MPI done within 60 days 
of coronary intervention or those with normal MPI but lost 
to follow-up were not included.
Stress protocol
Dynamic exercise (either Bruce or Modified Bruce protocol) 
was performed using treadmill and exercise was considered 
adequate when patient achieved ≥85% of age predicted 
target heart rate (220-age) or developed typical angina or 
dyspnea or >2 mm ST depressions in two or more leads. 
Beta blockers, calcium blocker and long acting nitrate 
were stopped 24-48 hours prior the test. Dipyridamole 
intervention was performed (0.567 mg/kg for 4 minutes) in 
patients who were unable to perform dynamic exercise or 
having left bundle branch block (LBBB) on resting ECG or 
specifically asked by the referring physicians due to limited 
exercise capacity. Tea, coffee and xanthine derivatives were 
stopped 24 prior in patients scheduled for dipyridamole 
test. A rise in ≥10 beats (from baseline) or drop of ≥10 mmHg 
of systolic blood pressure with or without symptoms or 
ST changes were considered as adequate response to 
dipyridamole. Tc-99m MIBI was given 1 minute before 
terminating exercise or 3-4 minutes after dipyridamole 
infusion.
Gated SPECT myocardial perfusion imaging
All patients underwent same day (rest-stress or stress-rest) 
myocardial perfusion GSPECT using Tc-99m MIBI. 10-
15 mCi (370-555 MBq) of Tc-99m MIBI was administered 
intravenously for first study (rest in rest-stress or stress 
in stress-rest protocol) and 25-30 mCi (925-1,110 MBq) 
for second study (stress in rest-stress or rest in stress-
rest protocol). Gated stress and non-gated rest SPECT 
acquisitions were performed using dedicated dual head 
cardiac (Cardio MD, Philips) gamma camera with low 
energy all purpose (LEAP) collimator, 32 projections around 
a 180-degree arc, a 64×64 matrix and 16 frames per cardiac 
cycle. Image reconstruction and LV functional parameters 
[EF, EDV, ESV and wall motion (WM)] were contemplated 
by using commercially available Astonish® and Autoquan® 
software packages respectively. An EF ≥50%, ESV ≤70 mL and 
WM score of zero (in a 17 segment model) were considered 
normal. Similarly, GMPI with SSS, SRS and SDS <2 were 
considered as normal. As per department protocol, to ensure 
optimal quality of scan, fatty meal with a glass of water 
prior the imaging was used to minimize sub-diaphragmatic 
activity and use of gated images (partial volume effect and 
wall motion) to rule out attenuation artifacts. No attenuation 
correction methodology was employed.
Follow-up
All patients/family were interviewed on telephone (median 
follow-up: 3.1 years; range: 2-5 years) regarding overall 
death, fatal or non-fatal MI. These events were confirmed 
by hospital records for those who were managed at our 
institute and by reviewing the discharge notes for those 
who were managed at other healthcare facilities. Cardiac 
death was defined as death caused by MI, significantcardiac 
arrhythmias, refractory congestive heart failure or 
unexplained sudden death.
Statistical analysis
Comparisons between patient groups were performed 
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using Student’s t-test for continuous variables and the χ2 
test for categorical variables. Continuous variables were 
described by mean ± standard deviation (SD). Kaplan-
Meier cumulative survival analysis for MACE like fatal 
and non-fatal MIs was performed, and survival curves were 
compared by the Logrank test. Univariate and multivariate 
Cox’s proportional hazard regression models were used to 
identify independent predictors of end points of interest. 
The risk of a variable was expressed as a hazard ratio 
with a corresponding 95% confidence interval. Statistical 
significance was defined as P<0.05. Commercially available 
packages Medcalc® and statistical package for social sciences 
(SPSS 17®) were used.
Results
The mean age of total 428 studied individuals was 56±10 years 
with a male to female ratio of 69%:31%. The average 
body mass index (BMI) of studied individuals was 26.660± 
5.172 Kg/m2 and 177 (41%) were found to be obese 
(BMI ≥30 Kg/m2). Prevalence of hypertension, diabetes, 
dyslipidemia and positive family history was 70%, 37%, 
33% and 37% respectively. Smoking (defined as current or 
left less than 05 years) was found in 80 (19%) individuals. 
Dynamic exercise was performed by 255 (60%) of individual 
while dipyridamole stress was used in 173 (40%) who were 
unable to perform dynamic stress. The mean age predicted 
heart rate achieved and functional capacity (as metabolic 
equivalents, METS) were (86±12)% and 8.805±4.944 
METS respectively. Mean left ventricular functional 
parameters like ejection fraction (%), end diastolic volume 
(EDV in mL) and end systolic volumes (ESV in mL) were 
(64±11)%, 87±33 and 33±24 mL respectively (Table 1).
Follow-up analysis
During a median follow-up of 3.1 years (range, 2-5 years), a 
total number of 60 patients (14%) died (all-cause mortality) 
with an annualized all-cause mortality rate of 2.8% 
(Figure 1). Cardiac deaths [fatal MI, congestive heart failure 
(CHF) or sudden unexplained death] was reported in 41 
(10%) patients with annualized cardiac mortality rate was 
2.0% (Figure 2). Nonfatal MI was reported in 77 patients 
(18%) with annualized event rate of 3.6% (Figure 3).
Predictors of long-term outcome
Smoking, CHF and failure to achieve 85% age predicted 
Table 1 Patients’ demographic with known coronary artery disease
Variables With normal MPI (n=428) t test/χ2 values P values
Age (average ± SD in years) 56±10 12.413 <0.0001*
Male:Female (%:%) 295:133 (69%:31%) 122.091 <0.0001*
BMI (average ± SD, Kg/m2) 26.660±5.172 93.361 <0.0001*
Obese 177 (41%) 3.724 0.0002*
Hypertension 299 (70%) 16.551 <0.0001*
Diabetes mellitus 157 (37%) 5.379 <0.0001*
Dyslipidemia 143 (33%) 7.034 <0.0001*
Family history for CAD 160 (37%) 5.379 <0.0001*
Smoking 80 (19%) 12.827 <0.0001*
Exercise 255 (60%) 4.138 <0.0001*
Pharmacological stress 173 (40%) 4.138 <0.0001*
METS 8.805±4.944 172.380 <0.0001*
% target heart rate (86±12)% 62.061 <0.0001*
LVEF (%) 64±11 26.660 <0.0001*
EDV (mL) 87±33 23.196 <0.0001*
ESV (mL) 33±24 14.654 <0.0001*
*P<0.05. MPI, myocardial perfusion imaging; SD, standard deviation; BMI, body mass index; CAD, coronary artery disease; METs, 
metabolic equivalent task; LVEF, left ventricular ejection fraction; EDV, end diastolic volume; ESV, end systolic volume.
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heart rate were found to be predictors for all-cause and 
cardiac mortality. Diabetes, dyslipidemia, smoking and 
limited functional capacity (<7 METS) were found to be 
predictors for non-fatal MI (Table 2).
Discussion
Over a long time as SPECT MPI has reached scientific 
and clinical maturity and we have grown to expect that 
the results of this test when negative, reliably predicts 
an excellent patients’ outcome. It is a well-established 
fact that annual probability of hard cardiac event with a 
normal exercise gated MPI is <1% (1-6). On the same 
note there has been an increase prevalence of normal MPI 
in patients with known CAD and this is primarily caused 
by remarkable improvement in medical therapy (statins 
mainly) and revascularization methodologies (8).The 
reasons for such clinical scenarios could be a patent graft 
or stent, presence of a haemodynamically non-significant 
stenosis, or a previous small (subendocardial) MI with a 
patent infarct-related coronary artery (4). In our study the 
all-cause mortality during the study period was 2.8% per 
year which is comparable with other published studies (4,6). 
However, the annual cardiac mortality and non-fatal MI 
rates in our study was 2% and 3.6% which are significantly 
higher than established ≈0.6% of average annual event 
rate in patients with a normal stress MPI (9). Our findings 
are in concordance with study by Acampa et al. (10) who 
studied 362 patients who had post-CABG normal MPIs 
with 22 month follow-up with a hard event rate (both fatal 
and non-fatal MIs) of 4%. Annualized cardiac and non-
fatal MI rate in our study (2% and 3.6%) when compared 
with similar studies published by Schinkel (4) (0.5% and 
1.4% in first 3 years follow-up) and Ottenhof et al. (7) (0.9% 
and 1.2% with 12 years follow-up) are significantly higher. 
Compared with these studies, our patients were younger, 
predominantly female with higher incidence of diabetes 
(37% vs. 10%) and hypertension (70% vs. about 50%). 
However, important to note that in Schinkels’ study (4) the 
annual cardiac mortality and cardiac mortality/non-fatal 
MI rate were increased to 1.3% and 3.1% during 4-6 years 
follow-up (0.5% and 1.4% in first 3-year follow-up) and 
closer to our findings with a median follow-up of 3.1 years. 
Another important aspect which draws our attention is the 
use of dipyridamole as mode of stress in 40% of our patients 
while previously mentioned studies included normal MPIs 
with dynamic exercise or with dobutamine stress. Recent 
Figure 1 Kaplan-Meier survival plot for all-cause mortalities in 
patients with normal MPI with known CAD. Event =60 (14%); 
Event rate (%/year): 2.8; Survival =86%. MPI, myocardial 
perfusion imaging; CAD, coronary artery disease.
Figure 2 Kaplan-Meier survival plot for cardiac mortalities in 
patients with normal MPI with known CAD. Events =41 (10%); 
Event rate (%/year): 2; Survival =90%. MPI, myocardial perfusion 
imaging; CAD, coronary artery disease.
Figure 3 Kaplan-Meier survival plot for non-fatal myocardial 
infarction in patients with normal MPI with known CAD. Events 
=77 (18%); Event rate (%/year): 3.6; Survival =82%. MPI, 
myocardial perfusion imaging; CAD, coronary artery disease.
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reports have shown a higher event rate in patients having a 
normal GMPI with vasodilators (dipyridamole or adenosine) 
than dynamic exercise (11,12). Therefore, higher incidence 
of diabetes and hypertension and use of vasodilator stress in 
40% of our patients are the major contributors for higher 
event rates in our study than other published data (4,6). 
Diabetes, dyslipidemia and smoking were independent risk 
factors for non-fatal MI while smoking, CHF and limited 
effort tolerance were risk factors for fatal MI. Pakistan is 
among the countries with highest incidence of diabetes 
with a reported figure of 13.14% (13). However, in our 
cohort, the incidence was 37% and this is due to referral 
bias. It is also an established fact that functional capacity of 
diabetics is lower as compared with non-diabetics (14) and 
this does explain the use of dipyridamole as stressor in 40% 
of participants of our study. Similarly the limited functional 
capacity in studied cohort who had dynamic exercise is a 
well-known risk factor for dismal outcome despite a normal 
MPI (15).
Findings of our study fuel the debate of safety profile 
of a normal MPI in patients with known CAD than in 
patients with suspected CAD where it is very high (cardiac 
event rate <1%). Higher event rates in this study puts a 
question mark over concept of warranty period in patients 
with known CAD and normal stress MPI (both exercise 
and vasodilator) as these patients had higher incidence 
of risk factors than patients cohorts reported in other 
studies (1,6). Based on multivariate analysis in this study, 
we suggest that patients with known CAD despite having 
a normal MPI need a close surveillance in the presence of 
risk factors like diabetes, dyslipidemia, history of smoking, 
limited effort tolerance and use of vasodilator as stressor. 
We strongly feel that in current era of effective medical 
and interventional strategies resulting in growing number 
of normal MPIs in patients with known CAD, more 
prospective studies are required to establish the safety 
profile of normal MPI in patients’ subset with known 
CAD and to design a cost effective but comprehensive 
surveillance strategy.
Our study has some limitations. (I) As coronary 
angiography was not routinely performed, odds of inclusion 
of false negative cases can be ruled out; (II) lack of data 
about how effectively diabetes and other risk factors were 
controlled as inadequate control of risk factors could be 
the reason for higher incidence during study period despite 
a normal MPI as noted in second half of follow-up in 
Schinkle’s study (4); (III) higher incidence of diabetes in 
studied population due to referral bias.
We conclude that patients with known CAD had higher 
cardiac event rates despite a normal stress SPECT MPI. 
Table 2 Multivariate predictors of clinical outcome by Cox hazard ratio with 95% confidence interval
Variables
Cox’s proportional hazard ratios with 95% confidence interval
All-cause motility Cardiac mortality Non-fatal MI/ischemia
Age >65 (years) 1.565 (0.552-4.438) 1.378 (0.408-4.648) 1.401 (0.557-3.526)
Age ≤65 (years) 0.639 (0.225-1.811) 0.726 (0.215-2.447) 0.713 (0.283-1.795)
Male gender 1.265 (0.577-2.772) 1.181 (0.467-2.985) 1.364 (0.686-2.714)
Obesity 0.481 (0.222-1.043) 0.489 (0.197-1.201) 0.895 (0.453-1.765)
Diabetes mellitus 1.426 (0.671-3.044) 1.307 (0.531-3.224) 2.579* (1.326-5.015)
Hypertension 0.758 (0.316-1.823) 0.927 (0.330-2.602) 0.505 (0.230-1.085)
Dyslipidemia 0.6839 (0.324-1.442) 1.004 (0.416-2.423) 2.156* (1.118-4.155)
Smoking 2.694* (1.098-6.609) 4.555* (1.558-13.324) 2.335* (1.053-5.178)
Family history 1.226 (0.572-2.632) 1.352 (0.547-3.339) 0.899 (0.460-1.761)
CHF 16.547* (4.397-62.271) 13.319* (2.745-64.639) 1.051 (0.314-3.511)
Previous infarction 1.189 (0.524-2.704) 1.676 (0.635-4.427) 1.016 (0.489-2.11)
Revascularization 0.588 (0.265-1.306) 0.550 (0.213-1.416) 0.724 (0.359-1.463)
MAPHR <85% 2.181* (1.028-4.626) 3.358* (1.377-8.186) 0.625 (0.332-1.215)
METS <7 0.742 (0.342-1.615) 0.466 (0.186-1.169) 7.765* (3.911-15.417)
*P<0.05. MI, myocardial infarction; CHF, congestive heart failure; MAPHR, maximal age predicted heart rate; METS, metabolic 
equivalent task.
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Diabetes, dyslipidemia, smoking and limited functional 
capacity were the predictors for fatal and non-fatal cardiac 
events. A cost effective but comprehensive surveillance 
strategy is warranted.
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